SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Robert Karlsson, Markus Aly, Mark Clements, Lilly Zheng, Jan Adolfsson, Jianfeng Xu, Henrik Grönberg, Fredrik Wiklund, A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk, European Urology, 2014, 65, 1, 169

    CrossRef

  2. 2
    Andreas Dinkel, Marielouise Kornmayer, Jürgen E. Gschwend, Birgitt Marten-Mittag, Peter Herschbach, Kathleen Herkommer, Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors, Familial Cancer, 2014,

    CrossRef

  3. 3
    Ola Bratt, The Clinical Impact of Genetic Susceptibility to Prostate Cancer, European Urology, 2014,

    CrossRef

  4. 4
    Liz Forbat, Morag Place, Daniel Kelly, Gill Hubbard, Kenny Boyd, Kate Howie, Hing Y. Leung, A cohort study reporting clinical risk factors and individual risk perceptions of prostate cancer: implications for PSA testing, BJU International, 2013, 111, 3
  5. 5
    Roberto L. Muller, Eliney F. Faria, Gustavo F. Carvalhal, Rodolfo B. Reis, Edmundo C. Mauad, Andre L. Carvalho, Stephen J. Freedland, Association between family history of prostate cancer and positive biopsies in a Brazilian screening program, World Journal of Urology, 2013, 31, 5, 1273

    CrossRef

  6. 6
    Massimo Lazzeri, Alexander Haese, Alberto Abrate, Alexandre Taille, Joan Palou Redorta, Thomas McNicholas, Giovanni Lughezzani, Giuliana Lista, Alessandro Larcher, Vittorio Bini, Andrea Cestari, Nicolòmaria Buffi, Markus Graefen, Olivier Bosset, Philippe Le Corvoisier, Alberto Breda, Pablo Torre, Linda Fowler, Jacques Roux, Giorgio Guazzoni, Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS project, BJU International, 2013, 112, 3
  7. 7
    Tudor Borza, Ramdev Konijeti, Adam S. Kibel, Early Detection, PSA Screening, and Management of Overdiagnosis, Hematology/Oncology Clinics of North America, 2013, 27, 6, 1091

    CrossRef

  8. 8
    Barbara Nemesure, Suh-Yuh Wu, Anselm Hennis, M. Cristina Leske, Family History of Prostate Cancer in a Black Population, Journal of Immigrant and Minority Health, 2013, 15, 6, 1107

    CrossRef

  9. 9
    Jielin Sun, Rong Na, Fang-Chi Hsu, S. Lilly Zheng, Fredrik Wiklund, Lynn D. Condreay, Jeffery M. Trent, Jianfeng Xu, Genetic Score Is an Objective and Better Measurement of Inherited Risk of Prostate Cancer than Family History, European Urology, 2013, 63, 3, 585

    CrossRef

  10. 10
    Shancheng Ren, Jianfeng Xu, Tie Zhou, Haowen Jiang, Haitao Chen, Fang Liu, Rong Na, Limin Zhang, Yishuo Wu, Jielin Sun, Bo Yang, Xu Gao, S. Lilly Zheng, Chuanliang Xu, Qiang Ding, Yinghao Sun, Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes, The Prostate, 2013, 73, 16
  11. 11
    M. E. McDowell, S. Occhipinti, R. A. Gardiner, S. K. Chambers, Prevalence and predictors of cancer specific distress in men with a family history of prostate cancer, Psycho-Oncology, 2013, 22, 11
  12. 12
    Jianfeng Xu, Jielin Sun, S Lilly Zheng, Prostate cancer risk-associated genetic markers and their potential clinical utility, Asian Journal of Andrology, 2013, 15, 3, 314

    CrossRef

  13. 13
    Florian R. Schroeck, Kimberly A. Zuhlke, Javed Siddiqui, Rabia Siddiqui, Kathleen A. Cooney, John T. Wei, Testing for the Recurrent HOXB13 G84E Germline Mutation in Men with Clinical Indications for Prostate Biopsy, The Journal of Urology, 2013, 189, 3, 849

    CrossRef

  14. 14
    Aubrey R. Turner, Junjie Feng, Wennuan Liu, Jin Woo Kim, Jianfeng Xu, Genomic and Personalized Medicine, 2013,

    CrossRef

  15. 15
    Song-Yi Park, Laurence N. Kolonel, Nutrition in the Prevention and Treatment of Disease, 2013,

    CrossRef

  16. 16
    C K M Ho, L Halley, J Wei, F K Habib, Analysis of prostate cancer association with four single-nucleotide polymorphisms from genome-wide studies and serum phyto-estrogen concentrations, Prostate Cancer and Prostatic Diseases, 2012, 15, 4, 365

    CrossRef

  17. 17
    Joan E Bailey-Wilson, Erica J Childs, Cheryl D Cropp, Daniel J Schaid, Jianfeng Xu, Nicola J Camp, Lisa A Cannon-Albright, James M Farnham, Asha George, Isaac Powell, John D Carpten, Graham G Giles, John L Hopper, Gianluca Severi, Dallas R English, William D Foulkes, Lovise Mæhle, Pål Møller, Rosalind Eeles, Douglas Easton, Michelle Guy, Steve Edwards, Michael D Badzioch, Alice S Whittemore, Ingrid Oakley-Girvan, Chih-Lin Hsieh, Latchezar Dimitrov, Janet L Stanford, Danielle M Karyadi, Kerry Deutsch, Laura McIntosh, Elaine A Ostrander, Kathleen E Wiley, Sarah D Isaacs, Patrick C Walsh, Stephen N Thibodeau, Shannon K McDonnell, Scott Hebbring, Ethan M Lange, Kathleen A Cooney, Teuvo LJ Tammela, Johanna Schleutker, Christiane Maier, Sylvia Bochum, Josef Hoegel, Henrik Grönberg, Fredrik Wiklund, Monica Emanuelsson, Geraldine Cancel-Tassin, Antoine Valeri, Olivier Cussenot, William B Isaacs, Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families, BMC Medical Genetics, 2012, 13, 1, 46

    CrossRef

  18. 18
    M. R. Akbari, J. Trachtenberg, J. Lee, S. Tam, R. Bristow, A. Loblaw, S. A. Narod, R. K. Nam, Association Between Germline HOXB13 G84E Mutation and Risk of Prostate Cancer, JNCI Journal of the National Cancer Institute, 2012, 104, 16, 1260

    CrossRef

  19. 19
    Adriana C. Vidal, Delores J. Grant, Christina D. Williams, Elizabeth Masko, Emma H. Allott, Kathryn Shuler, Megan McPhail, Alexis Gaines, Elizabeth Calloway, Leah Gerber, Jen-Tsan Chi, Stephen J. Freedland, Cathrine Hoyo, Associations between Intake of Folate, Methionine, and Vitamins B-12, B-6 and Prostate Cancer Risk in American Veterans, Journal of Cancer Epidemiology, 2012, 2012, 1

    CrossRef

  20. 20
    Lingyi Lu, Geraldine Cancel-Tassin, Antoine Valeri, Olivier Cussenot, Ethan M. Lange, Kathleen A. Cooney, James M. Farnham, Nicola J. Camp, Lisa A. Cannon-Albright, Teuvo L.J. Tammela, Johanna Schleutker, Josef Hoegel, Kathleen Herkommer, Christiane Maier, Walther Vogel, Fredrik Wiklund, Monica Emanuelsson, Henrik Grönberg, Kathleen E. Wiley, Sarah D. Isaacs, Patrick C. Walsh, Brian T. Helfand, Donghui Kan, William J. Catalona, Janet L. Stanford, Liesel M. FitzGerald, Bo Johanneson, Kerry Deutsch, Laura McIntosh, Elaine A. Ostrander, Stephen N. Thibodeau, Shannon K. McDonnell, Scott Hebbring, Daniel J. Schaid, Alice S. Whittemore, Ingrid Oakley-Girvan, Chih-Lin Hsieh, Isaac Powell, Joan E. Bailey-Wilson, Cheryl D. Cropp, Claire Simpson, John D. Carpten, Daniela Seminara, S. Lilly Zheng, Jianfen Xu, Graham G. Giles, Gianluca Severi, John L. Hopper, Dallas R. English, William D. Foulkes, Lovise Maehle, Pal Moller, Michael D. Badzioch, Steve Edwards, Michelle Guy, Ros Eeles, Douglas Easton, William B. Isaacs, Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG, The Prostate, 2012, 72, 4
  21. 21
    Kari Hemminki, Familial risk and familial survival in prostate cancer, World Journal of Urology, 2012, 30, 2, 143

    CrossRef

  22. 22
    William B Isaacs, Inherited susceptibility for aggressive prostate cancer, Asian Journal of Andrology, 2012, 14, 3, 415

    CrossRef

  23. 23
    J.-A. Thomas, L. Gerber, D. M. Moreira, R. J. Hamilton, L. L. Bañez, R. Castro-Santamaria, G. L. Andriole, W. B. Isaacs, J. Xu, S. J. Freedland, Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1), Journal of Internal Medicine, 2012, 272, 1
  24. 24
    Xiaoye Zhu, Peter C. Albertsen, Gerald L. Andriole, Monique J. Roobol, Fritz H. Schröder, Andrew J. Vickers, Risk-Based Prostate Cancer Screening, European Urology, 2012, 61, 4, 652

    CrossRef

  25. 25
    Kashif Shafique, Philip McLoone, Khaver Qureshi, Hing Leung, Carole Hart, David S. Morrison, Tea Consumption and the Risk of Overall and Grade Specific Prostate Cancer: A Large Prospective Cohort Study of Scottish Men, Nutrition and Cancer, 2012, 64, 6, 790

    CrossRef

  26. 26
    K Shafique, R Oliphant, D S Morrison, The impact of socio-economic circumstances on overall and grade-specific prostate cancer incidence: a population-based study, British Journal of Cancer, 2012, 107, 3, 575

    CrossRef

  27. 27
    Robert J. MacInnis, Antonis C. Antoniou, Rosalind A. Eeles, Gianluca Severi, Ali Amin Al Olama, Lesley McGuffog, Zsofia Kote-Jarai, Michelle Guy, Lynne T. O'Brien, Amanda L. Hall, Rosemary A. Wilkinson, Emma Sawyer, Audrey T. Ardern-Jones, David P. Dearnaley, Alan Horwich, Vincent S. Khoo, Christopher C. Parker, Robert A. Huddart, Nicholas Van As, Margaret R. McCredie, Dallas R. English, Graham G. Giles, John L. Hopper, Douglas F. Easton, A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact, Genetic Epidemiology, 2011, 35, 6
  28. 28
    Seung Hwan Lee, Kyung Kgi Park, Mun Su Chung, Byung Ha Chung, Clinical Features of Familial or Hereditary Prostate Cancer in Korean Men: A Pilot Study, Korean Journal of Urology, 2011, 52, 1, 9

    CrossRef

  29. You have free access to this content29
    Richard Flavin, Giorgia Zadra, Massimo Loda, Metabolic alterations and targeted therapies in prostate cancer, The Journal of Pathology, 2011, 223, 2
  30. 30
    Giuseppe Colloca, Antonella Venturino, The evolving role of familial history for prostate cancer, Acta Oncologica, 2011, 50, 1, 14

    CrossRef

  31. 31
    Stephan Madersbacher, Antonio Alcaraz, Mark Emberton, Peter Hammerer, Anton Ponholzer, Fritz H. Schröder, Andrea Tubaro, The influence of family history on prostate cancer risk: implications for clinical management, BJU International, 2011, 107, 5
  32. 32
    K. Herkommer, C. Schmidt, J.E. Gschwend, Zehn Jahre nationales Forschungsprojekt „Familiäres Prostatakarzinom“, Der Urologe, 2011, 50, 7, 813

    CrossRef

  33. 33
    Bin Xu, JinFeng Wang, Na Tong, YuanYuan Mi, ZhiChao Min, Jun Tao, PengChao Li, Gong Cheng, JiuMing Li, MeiLin Wang, JiaLin Tang, NingHong Song, ZhengDong Zhang, Wei Zhang, HongFei Wu, LiXin Hua, NingHan Feng, A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression, The Prostate, 2010, 70, 10
  34. 34
    Gayathri Sridhar, Saba W. Masho, Tilahun Adera, Viswanathan Ramakrishnan, John D. Roberts, Association between family history of cancers and risk of prostate cancer, Journal of Men's Health, 2010, 7, 1, 45

    CrossRef

  35. 35
    M.C.M. Goossens, Jacques De Grève, Individual cancer risk as a function of current age and risk profile, European Journal of Cancer Prevention, 2010, 19, 6, 485

    CrossRef

  36. 36
    Michael Marberger, Managing benign prostatic hyperplasia and prostate cancer – the challenges today, Journal of Men's Health, 2010, 7, 2, 113

    CrossRef

  37. 37
    Manish Kohli, Donald J. Tindall, New Developments in the Medical Management of Prostate Cancer, Mayo Clinic Proceedings, 2010, 85, 1, 77

    CrossRef

  38. 38
    Brian T. Helfand, Stacy Loeb, Donghui Kan, William J. Catalona, Number of prostate cancer risk alleles may identify possibly ‘insignificant’ disease, BJU International, 2010, 106, 11
  39. 39
    Robert J. MacInnis, Antonis C. Antoniou, Rosalind A. Eeles, Gianluca Severi, Michelle Guy, Lesley McGuffog, Amanda L. Hall, Lynne T. O'Brien, Rosemary A. Wilkinson, David P. Dearnaley, Audrey T. Ardern-Jones, Alan Horwich, Vincent S. Khoo, Christopher C. Parker, Robert A. Huddart, Margaret R. McCredie, Charmaine Smith, Melissa C. Southey, Margaret P. Staples, Dallas R. English, John L. Hopper, Graham G. Giles, Douglas F. Easton, Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies, Genetic Epidemiology, 2010, 34, 1
  40. 40
    B.J. Schmitz-Dräger, E. Bismarck, G. Lümmen, Risiken und Prävention des Prostatakarzinoms, Der Urologe, 2010, 49, 2, 233

    CrossRef

  41. 41
    M.E. MCDOWELL, S. OCCHIPINTI, R.A. GARDINER, P.D. BAADE, S.K. STEGINGA, A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer, European Journal of Cancer Care, 2009, 18, 6
  42. 42
    Andreas Meyer, Peter Schürmann, Maryam Ghahremani, Ertan Kocak, Maria-Jantje Brinkhaus, Michael Bremer, Johann H. Karstens, Jörn Hagemann, Stefan Machtens, Thilo Dörk, Association of chromosomal locus 8q24 and risk of prostate cancer: A hospital-based study of German patients treated with brachytherapy, Urologic Oncology: Seminars and Original Investigations, 2009, 27, 4, 373

    CrossRef

  43. 43
    J M Fitzpatrick, R S Kirby, C L Brough, A L Saggerson, Awareness of prostate cancer among patients and the general public: results of an international survey, Prostate Cancer and Prostatic Diseases, 2009, 12, 4, 347

    CrossRef

  44. 44
    Meredith Yeager, Zuoming Deng, Joseph Boland, Casey Matthews, Jennifer Bacior, Victor Lonsberry, Amy Hutchinson, Laura A. Burdett, Liqun Qi, Kevin B. Jacobs, Jesus Gonzalez-Bosquet, Sonja I. Berndt, Richard B. Hayes, Robert N. Hoover, Gilles Thomas, David J. Hunter, Michael Dean, Stephen J. Chanock, Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer, Human Genetics, 2009, 126, 6, 743

    CrossRef

  45. 45
    Arnoud Templeton, Giancarlo Marra, Emanuele Valtorta, Karl Heinimann, Hansjakob Müller, Dieter Köberle, Silke Gillessen, Concordant colon tumors in monozygotic twins previously treated for prostate cancer, Familial Cancer, 2009, 8, 2, 167

    CrossRef

  46. 46
    J. Zabaleta, L. J. Su, H.-Y. Lin, R. A. Sierra, M. C. Hall, A. O. Sartor, P. E. Clark, J. J. Hu, A. C. Ochoa, Cytokine genetic polymorphisms and prostate cancer aggressiveness, Carcinogenesis, 2009, 30, 8, 1358

    CrossRef

  47. 47
    H. Lou, M. Yeager, H. Li, J. G. Bosquet, R. B. Hayes, N. Orr, K. Yu, A. Hutchinson, K. B. Jacobs, P. Kraft, S. Wacholder, N. Chatterjee, H. S. Feigelson, M. J. Thun, W. R. Diver, D. Albanes, J. Virtamo, S. Weinstein, J. Ma, J. M. Gaziano, M. Stampfer, F. R. Schumacher, E. Giovannucci, G. Cancel-Tassin, O. Cussenot, A. Valeri, G. L. Andriole, E. D. Crawford, S. K. Anderson, M. Tucker, R. N. Hoover, J. F. Fraumeni, G. Thomas, D. J. Hunter, M. Dean, S. J. Chanock, Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility, Proceedings of the National Academy of Sciences, 2009, 106, 19, 7933

    CrossRef

  48. 48
    Roger S. Rittmaster, Neil E. Fleshner, Ian M. Thompson, Pharmacological Approaches to Reducing the Risk of Prostate Cancer, European Urology, 2009, 55, 5, 1064

    CrossRef

  49. 49
    A Murad, S J Lewis, G Davey Smith, S M Collin, L Chen, F C Hamdy, D E Neal, J Donovan, R M Martin, PTGS2–899G>C and prostate cancer risk: a population-based nested case–control study (ProtecT) and a systematic review with meta-analysis, Prostate Cancer and Prostatic Diseases, 2009, 12, 3, 296

    CrossRef

  50. 50
    Karim Chamie, Ralph W. deVere White, Dennis Lee, Joonha Ok, Lars M. Ellison, Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer, Cancer, 2008, 113, 9
  51. 51
    Faysal A Yafi, Armen G Aprikian, Wassim Kassouf, Chemoprevention of prostate cancer: agents, studies and future prospects, Aging Health, 2008, 4, 5, 469

    CrossRef

  52. 52
    Edward P. Gelmann, Complexities of Prostate-Cancer Risk, New England Journal of Medicine, 2008, 358, 9, 961

    CrossRef

  53. 53
    S. Lilly Zheng, Jielin Sun, Fredrik Wiklund, Shelly Smith, Pär Stattin, Ge Li, Hans-Olov Adami, Fang-Chi Hsu, Yi Zhu, Katarina Bälter, A. Karim Kader, Aubrey R. Turner, Wennuan Liu, Eugene R. Bleecker, Deborah A. Meyers, David Duggan, John D. Carpten, Bao-Li Chang, William B. Isaacs, Jianfeng Xu, Henrik Grönberg, Cumulative Association of Five Genetic Variants with Prostate Cancer, New England Journal of Medicine, 2008, 358, 9, 910

    CrossRef

  54. 54
    Yen-Ching Chen, John H. Page, Rong Chen, Edward Giovannucci, Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era, The Prostate, 2008, 68, 14
  55. 55
    Jiyoung Ahn, Roxana Moslehi, Stephanie J. Weinstein, Kirk Snyder, Jarmo Virtamo, Demetrius Albanes, Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study, International Journal of Cancer, 2008, 123, 5
  56. 56
    Megan Noe, Paul Schroy, Marie-France Demierre, Richard Babayan, Alan C. Geller, Increased cancer risk for individuals with a family history of prostate cancer, colorectal cancer, and melanoma and their associated screening recommendations and practices, Cancer Causes & Control, 2008, 19, 1, 1

    CrossRef

  57. 57
    C.E. Wakefield, B. Meiser, C.L. Gaff, A. Barratt, M.I. Patel, G. Suthers, E.A. Lobb, J. Ramsay, G.J. Mann, Issues Faced by Unaffected Men With a Family History of Prostate Cancer: A Multidisciplinary Overview, The Journal of Urology, 2008, 180, 1, 38

    CrossRef

  58. 58
    Donald T. Wigle, Michelle C. Turner, James Gomes, Marie-Élise Parent, Role of Hormonal and Other Factors in Human Prostate Cancer, Journal of Toxicology and Environmental Health, Part B, 2008, 11, 3-4, 242

    CrossRef

  59. 59
    Giorgia Randi, Claudio Pelucchi, Eva Negri, Renato Talamini, Carlotta Galeone, Silvia Franceschi, Carlo La Vecchia, Family history of urogenital cancers in patients with bladder, renal cell and prostate cancers, International Journal of Cancer, 2007, 121, 12
  60. 60
    Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Dean A. Troyer, Betsy Higgins, Donna Pauler Ankerst, Ian M. Thompson, Robin J. Leach, Dipen J. Parekh, Prostate Cancer Risk with Positive Family History, Normal Prostate Examination Findings, and PSA Less Than 4.0 ng/mL, Urology, 2007, 70, 4, 748

    CrossRef

  61. 61
    Silvano Gallus, Roberto Foschi, Renato Talamini, Andrea Altieri, Eva Negri, Silvia Franceschi, Maurizio Montella, Luigino Dal Maso, Valerio Ramazzotti, Carlo La Vecchia, Risk Factors for Prostate Cancer in Men Aged Less Than 60 Years: A Case–Control Study from Italy, Urology, 2007, 70, 6, 1121

    CrossRef

  62. 62
    S. Lilly Zheng, Wennuan Liu, Fredrik Wiklund, Latchezar Dimitrov, Katarina Bälter, Jielin Sun, Hans-Olov Adami, Jan-Erik Johansson, Jishan Sun, Baoli Chang, Matthew Loza, Aubrey R. Turner, Eugene R. Bleecker, Deborah A. Meyers, John D. Carpten, David Duggan, William B. Isaacs, Jianfeng Xu, Henrik Grönberg, A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study, The Prostate, 2006, 66, 14
  63. 63
    Benjamin A. Spencer, Susan H. Babey, David A. Etzioni, Ninez A. Ponce, E. Richard Brown, Hongjian Yu, Neetu Chawla, Mark S. Litwin, A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma, Cancer, 2006, 106, 4
  64. 64
    Timothy C. Brand, Edith D. Canby-Hagino, A. Pratap Kumar, Rita Ghosh, Robin J. Leach, Ian M. Thompson, Chemoprevention of Prostate Cancer, Hematology/Oncology Clinics of North America, 2006, 20, 4, 831

    CrossRef

  65. 65
    Sameer A. Siddiqui, Shomik Sengupta, Jeffrey M. Slezak, Eric J. Bergstralh, Horst Zincke, Michael L. Blute, Impact of Familial and Hereditary Prostate Cancer on Cancer Specific Survival After Radical Retropubic Prostatectomy, The Journal of Urology, 2006, 176, 3, 1118

    CrossRef

  66. 66
    Laura Baglietto, Mark A. Jenkins, Gianluca Severi, Graham G. Giles, D. Timothy Bishop, Peter Boyle, John L. Hopper, Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer, Journal of Clinical Epidemiology, 2006, 59, 2, 114

    CrossRef

  67. 67
    Randi L. Shand, Edward P. Gelmann, Molecular biology of prostate-cancer pathogenesis, Current Opinion in Urology, 2006, 16, 3, 123

    CrossRef

  68. 68
    Daniel J. Schaid, Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics, Human Genetics, 2006, 120, 4, 471

    CrossRef

  69. 69
    Mikel Gray, Terran Sims, Prostate Cancer, The Nurse Practitioner, 2006, 31, 9, 14???29

    CrossRef

  70. 70
    Glenn R Cunningham, Testosterone replacement therapy for late-onset hypogonadism, Nature Clinical Practice Urology, 2006, 3, 5, 260

    CrossRef

  71. 71
    Jonathan C. Routh, Bradley C. Leibovich, Adenocarcinoma of the Prostate: Epidemiological Trends, Screening, Diagnosis, and Surgical Management of Localized Disease, Mayo Clinic Proceedings, 2005, 80, 7, 899

    CrossRef

  72. 72
    Jonathan P. Terdiman, Colorectal cancer at a young age, Gastroenterology, 2005, 128, 4, 1067

    CrossRef

  73. 73
    Daniel J. Schaid, Bao Li Chang, Description of the international consortium for prostate cancer genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13, The Prostate, 2005, 63, 3
  74. 74
    Emilio Sacco, Tommaso Prayer-Galetti, Francesco Pinto, Matteo Ciaccia, Simonetta Fracalanza, Giovanni Betto, Francesco Pagano, Familial and Hereditary Prostate Cancer by Definition in an Italian Surgical Series: Clinical Features and Outcome, European Urology, 2005, 47, 6, 761

    CrossRef

  75. 75
    Kari Hemminki, Bowang Chen, Familial association of prostate cancer with other cancers in the Swedish Family-Cancer Database, The Prostate, 2005, 65, 2
  76. 76
    Eva Negri, Claudio Pelucchi, Renato Talamini, Maurizio Montella, Silvano Gallus, Cristina Bosetti, Silvia Franceschi, Carlo La Vecchia, Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia, International Journal of Cancer, 2005, 114, 4
  77. 77
    Lisa A. Cannon Albright, Angela Schwab, Nicola J. Camp, James S. Farnham, Alun Thomas, Population-based risk assessment for other cancers in relatives of hereditary prostate cancer (HPC) cases, The Prostate, 2005, 64, 4
  78. 78
    Adina R. Lemeshow, Robin E. Blum, Jesse A. Berlin, Michael A. Stoto, Graham A. Colditz, Searching one or two databases was insufficient for meta-analysis of observational studies, Journal of Clinical Epidemiology, 2005, 58, 9, 867

    CrossRef

  79. 79
    Clara L. Gaff, Clelia Aragona, Robert J. MacInnis, Ruth Cowan, Charmaine Payne, Graham G. Giles, Geoffrey J. Lindeman, Accuracy and completeness in reporting family history of prostate cancer by unaffected men, Urology, 2004, 63, 6, 1111

    CrossRef

  80. 80
    David G. Bostwick, Harry B. Burke, Daniel Djakiew, Susan Euling, Shuk-mei Ho, Joseph Landolph, Howard Morrison, Babasaheb Sonawane, Tiffany Shifflett, David J. Waters, Barry Timms, Human prostate cancer risk factors, Cancer, 2004, 101, S10
  81. 81
    Stephen M. Edwards, Rosalind A. Eeles, Unravelling the genetics of prostate cancer, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2004, 129C, 1
  82. 82
    Annie Darves-Bornoz, Joe Park, Aaron Katz, Prostate Cancer Epidemiology,